WHO ICTRP trial
The effect of probiotics supplementation in type 1 diabetic patients
IRCT20201203049576N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20201203049576N1 |
|---|---|
| Public title | The effect of probiotics supplementation in type 1 diabetic patients |
| Scientific title | The effect of probiotics supplementation on glycemic control and metabolic parameters in type 1 diabetic patients |
| Primary sponsor | Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Type 1 diabetes mellitus. Type 1 diabetes mellitus |
| Interventions | Intervention 1: The intervention group will receive a probiotic supplement capsule. This supplement will be produced by the tak gene zist company, which consists of 6 bacterial strains including Lactobacillus acidophilus, Lactobacillus… |
| Registration date | Dec 28, 2020 |
| Target size | 64 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: